Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2024

Jan 3, 2024

30403_dirs_2024-01-03_0428d863-13bd-4cbe-bc01-1d0c2e04f6a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2023-12-29

Reporting Person: MACKAY A D DAVID (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-10 Deferred Stock Units $ A 51.0887 Acquired Common Stock (51.0887) Direct
2023-05-12 Deferred Stock Units $ A 45.8207 Acquired Common Stock (45.8207) Direct
2023-08-25 Deferred Stock Units $ A 51.3556 Acquired Common Stock (51.3556) Direct
2023-11-09 Deferred Stock Units $ A 60.4415 Acquired Common Stock (60.4415) Direct
2023-12-29 Deferred Stock Units $ A 1117.3538 Acquired Common Stock (1117.3538) Direct

Footnotes

F1: 1-for-1

F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.